CBL-b E3 ligase-mediated neddylation and activation of PARP-1 induce vascular calcification

被引:0
|
作者
Kwon, Duk-Hwa [1 ,2 ,3 ]
Shin, Sera [1 ,2 ]
Nam, Yoon Seok [4 ,5 ]
Choe, Nakwon [1 ,2 ]
Lim, Yongwoon [1 ,2 ]
Jeong, Anna [1 ,2 ,3 ]
Lee, Yun-Gyeong [1 ,2 ]
Kim, Young-Kook [3 ,6 ]
Kook, Hyun [1 ,2 ,3 ]
机构
[1] Chonnam Natl Univ, Sch Med, Dept Pharmacol, Hwasun, Jeollanamdo, South Korea
[2] Chonnam Natl Univ, Sch Med, Basic Res Lab Vasc Remodeling, Hwasun, Jeollanamdo, South Korea
[3] Chonnam Natl Univ, BK21 Plus Ctr Creat Biomed Scientists, Gwangju, South Korea
[4] Chosun Univ, Inst Well Aging Medicare, Gwangju, South Korea
[5] Chosun Univ, CSU G LAMP Project Grp, Gwangju, South Korea
[6] Chonnam Natl Univ, Sch Med, Dept Biochem, Hwasun, Jeollanamdo, South Korea
来源
EXPERIMENTAL AND MOLECULAR MEDICINE | 2024年 / 56卷 / 10期
基金
新加坡国家研究基金会;
关键词
NEDD8-ACTIVATING ENZYME; ADP-RIBOSYLATION; INHIBITOR; DISEASES;
D O I
10.1038/s12276-024-01322-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular calcification (VC) refers to the accumulation of mineral deposits on the walls of arteries and veins, and it is closely associated with increased mortality in cardiovascular disease patients, particularly among high-risk patients with diabetes and chronic kidney disease (CKD). Neuronal precursor cell-expressed developmentally downregulated protein 8 (NEDD8) is a ubiquitin-like protein that plays a pivotal role in various cellular functions, primarily through its conjugation to target proteins and subsequent relay of biological signals. However, the role of NEDDylation in VC has not been investigated. In our study, we observed that MLN4924, an inhibitor of the NEDD8-activating E1 enzyme, effectively impedes the progression of VC. LCMS/MS analysis revealed that poly(ADPribose) polymerase 1 (PARP-1) is subjected to NEDD8 conjugation, leading to an increase in PARP-1 activity during VC. We subsequently revealed that PARP-1 NEDDylation is mediated by the E3 ligase CBL proto-oncogene B (CBL-b) and is reversed by NEDD8-specific protease 1 (NEDP-1) during VC. Furthermore, the CBL-b C373 peptide effectively mitigated the inactive form of the E3 ligase activity of CBL-b, ultimately preventing VC. These findings provide compelling evidence that the NEDD8-dependent activation of PARP-1 represents a novel mechanism underlying vascular calcification and suggests a promising new therapeutic target for VC.
引用
收藏
页码:2246 / 2259
页数:14
相关论文
共 50 条
  • [31] T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells
    Zhao, Yixia
    Qiao, Guilin
    Yang, Tianlun
    Zhang, Jian
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [32] Photochemical Dimerization of Plakinidine B Leads to Potent Inhibition of the E3 Ubiquitin-Protein Ligase CBL-B
    Khong, Quan T.
    Li, Donghao
    Wilson, Brice A. P.
    Ranguelova, Kalina
    Dalilian, Masoumeh
    Smith, Emily A.
    Wamiru, Antony
    Goncharova, Ekaterina I.
    Grkovic, Tanja
    Voeller, Donna
    Lipkowitz, Stanley
    Schnermann, Martin J.
    O'Keefe, Barry R.
    Du, Lin
    ORGANIC LETTERS, 2022, 24 (51) : 9468 - 9472
  • [33] The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
    Paolino, Magdalena
    Choidas, Axel
    Wallner, Stephanie
    Pranjic, Blanka
    Uribesalgo, Iris
    Loeser, Stefanie
    Jamieson, Amanda M.
    Langdon, Wallace Y.
    Ikeda, Fumiyo
    Fededa, Juan Pablo
    Cronin, Shane J.
    Nitsch, Roberto
    Schultz-Fademrecht, Carsten
    Eickhoff, Jan
    Menninger, Sascha
    Unger, Anke
    Torka, Robert
    Gruber, Thomas
    Hinterleitner, Reinhard
    Baier, Gottfried
    Wolf, Dominik
    Ullrich, Axel
    Klebl, Bert M.
    Penninger, Josef M.
    NATURE, 2014, 507 (7493) : 508 - +
  • [34] Regulation of T Follicular Helper Cells in Systemic Lupus Erythematosus By E3 Ubiquitin Ligase Cbl-b
    Willis, William
    Xiao, Yun
    Young, Nicholas A.
    Jarjour, Wael N.
    Zhang, Jian
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [35] E3 Ubiquitin Ligase Cbl-b Suppresses Proallergic T Cell Development and Allergic Airway Inflammation
    Qiao, Guilin
    Ying, Haiyan
    Zhao, Yixia
    Liang, Yanran
    Guo, Hui
    Shen, Huifeng
    Li, Zhenping
    Solway, Julian
    Tao, Enxiang
    Chiang, Y. Jeffrey
    Lipkowitz, Stanley
    Penninger, Josef M.
    Langdon, Wallace Y.
    Zhang, Jian
    CELL REPORTS, 2014, 6 (04): : 709 - 723
  • [36] Cbl-b E3 ubiquitin ligase regulates autoimmune responses via T cell anergy induction
    Jeon, MS
    Venuprasad, K
    Yang, C
    Elly, C
    Liu, YC
    FASEB JOURNAL, 2005, 19 (04): : A913 - A913
  • [37] The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
    Magdalena Paolino
    Axel Choidas
    Stephanie Wallner
    Blanka Pranjic
    Iris Uribesalgo
    Stefanie Loeser
    Amanda M. Jamieson
    Wallace Y. Langdon
    Fumiyo Ikeda
    Juan Pablo Fededa
    Shane J. Cronin
    Roberto Nitsch
    Carsten Schultz-Fademrecht
    Jan Eickhoff
    Sascha Menninger
    Anke Unger
    Robert Torka
    Thomas Gruber
    Reinhard Hinterleitner
    Gottfried Baier
    Dominik Wolf
    Axel Ullrich
    Bert M. Klebl
    Josef M. Penninger
    Nature, 2014, 507 : 508 - 512
  • [38] E3 ubiquitin ligase CBL-B suppresses vascular endothelial cell pyroptosis and injury in intracranial aneurysm by facilitating NLRP3 degradation
    Zheng, Wei
    Liu, Cheng
    BIOCELL, 2024, 48 (02) : 293 - 301
  • [39] E3 Ubiquitin Ligase-Mediated Regulation of Osteoblast Differentiation and Bone Formation
    Shen, Jianlin
    Fu, Bowen
    Li, Yanfang
    Wu, Yanjiao
    Sang, Hongxun
    Zhang, Heshi
    Lin, Haibin
    Liu, Huan
    Huang, Wenhua
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [40] E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor-mediated antifungal innate immunity
    Zhu, Le-Le
    Luo, Tian-Ming
    Xu, Xia
    Guo, Ya-Hui
    Zhao, Xue-Qiang
    Wang, Ting-Ting
    Tang, Bing
    Jiang, Yuan-Ying
    Xu, Jin-Fu
    Lin, Xin
    Jia, Xin-Ming
    JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (08): : 1555 - 1570